https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/saklighet/artikel-1/2015-11-16T10:20:00+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/saklighet/artikel-2/2021-06-30T16:14:45+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/saklighet/artikel-3/2015-11-12T11:12:18+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/vederhaftighet/artikel-4/2025-09-29T09:59:07+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/identifierbarhet/artikel-5/2016-02-02T16:52:09+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/identifierbarhet/artikel-6/2025-09-29T09:59:17+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/aktualitet/artikel-7/2025-09-29T09:59:24+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/dokumentation-och-dess-aberopande/artikel-8/2021-06-30T15:58:20+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/dokumentation-och-dess-aberopande/artikel-9/2015-11-12T11:11:44+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/dokumentation-och-dess-aberopande/artikel-10/2015-11-12T11:11:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/dokumentation-och-dess-aberopande/artikel-11/2025-09-29T09:59:53+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/jamforande-information/artikel-12/2025-09-29T10:00:01+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/misskreditering/artikel-13/2016-02-02T16:54:54+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/regler-om-informationens-spridning/artikel-14/2025-09-29T10:00:13+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/regler-om-informationens-spridning/artikel-15/2025-09-29T10:00:17+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-16/2015-11-12T11:10:55+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-17/2026-01-30T09:07:27+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-18/2021-09-14T10:12:10+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-19/2021-06-30T15:58:58+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-20/2015-11-12T11:10:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-21/2025-09-29T10:00:42+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-22/2025-09-29T10:00:47+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-23/2025-09-29T10:00:51+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-24/2025-09-29T10:00:56+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/artikel-25/2025-09-29T10:01:00+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/lakemedelsprover/artikel-26/2025-09-29T10:01:08+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/ansvarsregler/artikel-27/2015-11-12T11:10:05+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/ansvarsbarare/artikel-28/2015-11-12T11:09:56+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/ansvarsbarare/artikel-29/2025-09-29T10:01:21+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/bevisskyldighet/artikel-30/2016-12-14T13:12:29+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/pliktexemplar/artikel-31/2025-09-29T10:01:31+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/saklighet/artikel-101/2025-09-29T10:01:56+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/saklighet/anvisningar/2025-09-29T10:02:01+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/saklighet/artikel-102/2025-09-29T10:02:05+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/saklighet/artikel-102-a/2016-12-14T13:23:12+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/saklighet/artikel-103/2015-11-12T11:32:57+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/vederhaftighet/artikel-104/2025-09-29T10:02:22+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/identifierbarhet/artikel-105/2025-09-29T10:02:28+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/identifierbarhet/anvisningar/2025-09-29T10:02:33+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/identifierbarhet/artikel-106/2025-09-29T10:02:38+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/aktualitet/artikel-107/2025-09-29T10:02:44+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/dokumentation-och-dess-aberopande/artikel-108/2021-06-30T16:00:21+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/dokumentation-och-dess-aberopande/artikel-109/2015-11-12T11:43:51+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/dokumentation-och-dess-aberopande/artikel-110/2015-11-12T11:43:46+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/dokumentation-och-dess-aberopande/artikel-111/2025-09-29T10:02:56+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/jamforande-information/artikel-112/2025-09-29T10:03:03+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/misskreditering/artikel-113/2015-11-12T11:46:52+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/regler-om-informationens-spridning/artikel-114/2025-09-29T10:03:14+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/regler-om-informationens-spridning/artikel-115/2025-09-29T10:03:17+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-116/2015-11-12T12:02:36+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-117/2026-01-30T09:07:46+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/anvisningar/2025-09-29T10:03:29+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-117-a/2015-11-12T12:01:40+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-118/2015-11-12T12:01:32+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-119/2015-11-12T12:01:19+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-120/2015-11-12T12:01:12+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-121/2015-11-12T12:00:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-122/2015-11-12T12:01:01+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/artikel-123-126/2015-11-12T12:00:19+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/ansvarsregler/artikel-127/2015-11-12T12:03:57+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/ansvarsbarare/artikel-128/2015-11-12T12:07:04+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/ansvarsbarare/artikel-129/2025-09-29T10:03:57+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/bevisskyldighet/artikel-130/2015-11-12T12:08:07+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/pliktexemplar/artikel-131/2025-09-29T10:04:11+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/samverkansreglernas-omfattning/artikel-1/2026-01-30T09:09:35+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/barande-principer-och-regler/artikel-2/2026-01-30T09:09:45+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/barande-principer-och-regler/artikel-2a/2026-01-30T09:09:50+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/barande-principer-och-regler/artikel-2b/2026-01-30T09:09:55+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/produktinformation/artikel-4/2026-01-30T09:10:16+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/ovriga-sammankomster/artikel-5/2026-01-30T09:10:23+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/a-sammankomster-arrangerade-av-industrin/artikel-5-a/2026-01-30T09:10:32+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/b-sammankomster-gemensamt-arrangerade-av-halso-och-sjukvarden-och-industrin/artikel-5-b/2026-01-30T09:10:39+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/konsultation-for-industrin/artikel-6/2026-01-30T09:11:10+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/marknadsundersokningar/artikel-10/2026-01-30T09:12:01+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/stipendier/artikel-7/2026-01-30T09:11:18+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/donationer/artikel-8/2026-01-30T09:11:27+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/informations--och-utbildningsmaterial-samt-hjalpmedel/artikel-11/2026-01-30T09:12:10+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/kliniska-provningar/artikel-12/2026-01-30T09:12:21+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/definitioner/artikel-1/2025-09-29T10:06:44+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/rapporteringsskyldighetens-omfattning/artikel-2/2025-09-29T10:06:51+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/tidpunkt-for-oppen-rapportering/artikel-3/2018-02-16T09:47:35+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/hur-oppen-rapportering-ska-ske/artikel-4/2025-09-29T10:07:03+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/rapporteringsplattform/artikel-5/2025-09-29T10:07:09+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/tillampligt-regelverk/artikel-6/2015-11-12T13:14:13+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/sprak/artikel-7/2015-11-12T13:15:08+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/dokumentering-och-forvaring-av-uppgifter/artikel-8/2015-11-12T13:16:27+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/individuell-rapportering/artikel-9/2021-06-30T16:03:58+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/aggregerad-rapportering/artikel-10/2025-09-29T10:07:33+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/indirekt-vardeoverforing-till-halso--och-sjukvardspersonal/artikel-11/2015-11-12T13:20:06+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/vardeoverforing-for-forskning-och-utveckling/artikel-12/2015-11-12T13:21:03+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/oppenhet-och-avtal/artikel-1/2025-09-29T10:08:17+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/konsultation/artikel-3/2025-09-29T10:08:34+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/konsultation-och-uppdrag/artikel-1/2025-09-29T10:09:37+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/arrangemang/artikel-2/2015-11-12T14:30:46+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/fortaring-kostnader-och-ersattning/artikel-3/2015-11-12T14:31:47+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/gavor/artikel-4/2015-11-12T14:33:20+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/kampanjbidrag-ovriga-formaner-m.m/artikel-5/2015-11-12T14:35:20+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/studien-sker-inom-ordinarie-sjukvard/artikel-1/2025-09-29T10:10:23+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/ansvarig-sjukvardshuvudman/artikel-2/2015-11-12T14:42:08+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/regional-etikprovningsnamnd/artikel-3/2015-11-12T14:42:44+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/studieplanprotokoll/artikel-4/2020-08-05T11:07:49+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/dataskyddsforordningen/artikel-5/2025-09-29T10:10:49+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/agande-av-data/artikel-6/2015-11-12T14:46:38+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/foretagets-interna-process/artikel-7/2015-11-12T14:47:25+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-2/forutsattningar-for-ekonomiskt-stod-till-nationella-kvalitetsregister/artikel-1/2020-08-05T11:09:12+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/terminologi/2016-12-14T14:02:19+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/forhandsgranskning/2016-12-14T14:03:02+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/marknadsbevakningen/2025-09-29T10:15:57+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/arendebedomningen-hos-ign/2016-12-14T14:04:22+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/forhandsgranskning2/2016-12-14T14:05:31+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/initiativarenden/2020-08-05T11:16:51+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/anmalningsarenden/2025-09-29T10:16:15+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/hanskjutande-till-nbl/2025-09-29T10:16:19+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/arendebedomningen-hos-nbl/2015-11-12T18:17:11+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/anhangiggorande/2021-06-30T16:08:07+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/arendeberedning/2025-09-29T10:16:29+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/arendeprovning-och-beslut/2016-12-14T14:11:53+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/vagledande-uttalanden/2016-12-14T14:12:23+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/myndighetsarenden/2016-12-14T14:12:38+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/utanforstaende-foretag/2025-09-29T10:16:43+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/huvudman-och-verksamhetsomrade/2020-08-05T11:09:51+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/uppgift/2016-12-14T13:42:24+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/verksamhetsinriktning/2025-09-29T10:14:13+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/arendefordelning/2020-08-05T11:10:22+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/arbetsordning/2016-12-14T13:44:04+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/organisation/2025-09-29T10:14:22+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/taleratt/2025-09-29T10:14:26+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/upphorandeuppmaning/2016-12-14T13:50:00+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/beslutsforhet-vid-slutliga-beslut-samt-vid-utfardande-av-varning/2025-09-29T10:14:36+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/interimistiskt-beslut/2016-12-14T13:53:13+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/handlaggningsbeslut/2016-12-14T13:54:21+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/jav/2016-12-14T13:55:20+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/slutliga-beslut-och-vagledande-uttalanden/2016-12-14T13:55:52+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/overklagande-till-nbl/2020-08-05T11:14:30+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/protokoll-och-verksamhetsberattelser/2020-08-05T11:14:40+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/offentlighet-handlingssekretess-och-tystnadsplikt/2016-12-14T13:57:17+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/avgifter/2018-02-16T09:57:42+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/forseningsavgift/2016-12-14T13:59:21+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/inbetalning/2015-11-12T17:39:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/annonsering/2015-11-12T17:35:00+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/rattelseannonsering/2016-12-14T13:59:35+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/disciplinara-atgarder/2020-08-05T11:15:46+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/administrativa-bestammelser/2022-06-22T08:49:09+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/antagande-och-andring-av-stadgarna/2025-09-29T10:15:24+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/kvalitetssakring/artikel-8/2015-11-12T14:48:10+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/lakemedelsverket/artikel-9/2015-11-12T14:48:50+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/offentliggorande/artikel-10/2015-11-12T14:49:30+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/riskminimeringsinformation-rmi---sarskild-information-och-atgarder-i-syfte-att-sakerstalla-korrekt-och-sakert-handhavande-och-funktion/artikel-3/2026-01-30T09:10:06+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/c-sammankomster-arrangerade-av-halso--och-sjukvarden-eller-tredje-part/artikel-5-c/2026-01-30T09:10:57+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/utvecklingsprojekt-dar-halso--och-sjukvarden-och-lakemedelsforetag-samverkar/artikel-9/2026-01-30T09:11:36+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/sammankomster-och-aktiviteter-arrangerade-av-lakemedelsforetag/artikel-2/2025-09-29T10:08:28+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/informations--och-utbildningsmaterial-hjalpmedel-och-patientstodsprogram/artikel-4/2025-09-29T10:09:09+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/sammankomster-och-aktiviteter-arrangerade-av-lakemedelsforetag-i-samarbete-med-organisation/artikel-5/2025-09-29T10:09:16+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/sammankomster-och-aktiviteter-arrangerade-av-eller-pa-uppdrag-av-organisation/artikel-6/2025-09-29T10:09:22+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-3/riktlinjer-for-marknadsforing-av-receptfria-lakemedel-pa-mobiltelefon-och-lasplattor/bakgrund/2025-09-29T10:16:58+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-3/riktlinjer-for-marknadsforing-av-receptfria-lakemedel-pa-mobiltelefon-och-lasplattor/artikel-1.-obligatorisk-information-minimi-information2025-09-29T10:17:03+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-3/riktlinjer-for-marknadsforing-av-receptfria-lakemedel-pa-mobiltelefon-och-lasplattor/artikel-2.-annonsens-utformning2025-09-29T10:17:06+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/patientstodsprogram/artikel-9-a/2026-01-30T09:11:50+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-3/riktlinjer-for-marknadsforing-av-receptfria-lakemedel-pa-mobiltelefon-och-lasplattor/2020-10-16T08:51:24+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2021/12/2021-12-06-folkhalsodalen/2025-10-08T21:14:04+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/3/2022-03-08-nordic-biobank-conference-2022/2025-10-08T21:14:02+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/3/how-stockholm-uppsala-is-keeping-global-infections-at-bay/2025-10-08T21:14:01+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/3/varfor-far-vi-inte-mer-vard-for-pengarna/2025-10-08T21:14:02+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/5/varmote-om-lakemedel-i-region-ostergotland/2025-10-08T21:13:52+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/5/motesplats-lakemedel/2025-10-08T21:13:52+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/5/launch-of-atmp-2030/2025-10-08T21:13:51+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/6/future-clinical-trials--from-tomorrow-to-2030--why-choose-the-nordics/2025-10-08T21:13:51+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/6/jamlika-samhallen-kraver-hallbar-halsa/2025-10-08T21:13:50+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/8/framtidens-lakemedelsutveckling/2025-10-08T21:13:48+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/10/avancerade-terapier--region-skanes-ambitioner/2025-10-08T21:13:38+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/10/samverkansdagen-2022-precisionsmedicin--ett-skifte-mot-individanpassad-diagnostik-och-behandling/2025-10-08T21:13:37+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/10/vad-hander-under-sveriges-eu-ordforandeskap/2025-10-08T14:51:56+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2021/6/lakemedel-och-halsoekonomi/2025-10-08T21:14:05+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/4/swecarnets-utbildningsdag-2022/2025-10-08T21:13:58+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/4/att-varda-over-granserna--ett-samhallsperspektiv-utan-stupror/2025-10-08T21:14:01+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/4/lansering-av-lifs-handlingsplan-mot-antibiotikaresistens/2025-10-08T21:13:58+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/4/nordic-precision-medicine-forum-2022/2025-10-08T21:13:57+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/4/mote-med-socialdepartementet-om-sarlakemedel/2025-10-08T21:14:01+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/9/eftervalsanalys-med-lif/2025-10-08T21:13:48+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/9/halsoekonomiskt-seminarium--skattningar-av-langtidsoverlevnad/2025-10-08T21:13:50+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/9/sjukt-viktigt--sa-ska-life-science-sektorn-na-de-globala-hallbarhetsmalen/2025-10-08T21:13:48+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/11/life-science-2.0--safeguarding-life2025-10-08T21:13:27+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/11/atmp-sweden-2022-stockholm/2025-10-08T21:13:37+02:00weekly0.5https://www.lif.se/event/_/enskilda-event/2022/11/arets-samhallsaktor/2025-10-08T21:13:37+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-2/bakgrund-och-syfte/2025-09-29T10:11:21+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-2/forutsattningar-for-ekonomiskt-stod-till-nationella-kvalitetsregister/2016-02-02T17:10:31+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-1/rapportmall/2025-09-29T10:13:51+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/stadgar-for-informationsgranskningsnamnden-ign-och-namnden-for-bedomning-av-lakemedelsinformation-nbl/2016-12-14T13:40:44+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/arbetsordning-for-ign-och-nbl/2025-09-29T10:15:35+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/konsultation-och-uppdrag/2015-11-12T14:29:36+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/arrangemang/2015-11-12T14:29:53+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/fortaring-kostnader-och-ersattning/2015-11-12T14:31:57+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/gavor/2015-11-12T14:33:24+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/kampanjbidrag-ovriga-formaner-m.m2015-11-12T14:33:50+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/bakgrund-och-syfte/2025-09-29T10:10:08+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/skillnader-icke-interventionsstudie--klinisk-provning/2015-11-12T14:38:59+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/nar-icke-interventionsstudier-kan-bli-aktuella/2015-11-12T14:39:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/forutsattningar-for-icke-interventionsstudier/2015-11-12T14:41:11+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/studien-sker-inom-ordinarie-sjukvard/2015-11-12T14:41:06+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/ansvarig-sjukvardshuvudman/2015-11-12T14:42:53+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/regional-etikprovningsnamnd/2015-11-12T14:42:49+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/studieplanprotokoll/2015-11-12T14:44:52+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/dataskyddsforordningen/2025-09-29T10:10:43+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/agande-av-data/2015-11-12T14:46:20+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/foretagets-interna-process/2015-11-12T14:47:33+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/kvalitetssakring/2015-11-12T14:47:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/lakemedelsverket/2015-11-12T14:48:54+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/offentliggorande/2015-11-12T14:49:06+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/bakgrund-och-syfte/2025-09-29T10:08:00+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/oppenhet-och-avtal/2015-11-12T13:52:57+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/konsultation/2020-04-21T13:58:09+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/provning-i-ign-och-nbl/2020-04-21T14:10:36+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/omfattning/2025-09-29T10:08:04+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/grundlaggande-principer/2025-09-29T10:08:07+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/grundlaggande-regler/2025-09-29T10:08:11+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/sammankomster-och-aktiviteter-arrangerade-av-lakemedelsforetag/2020-04-29T09:39:02+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/informations--och-utbildningsmaterial-hjalpmedel-och-patientstodsprogram/2020-04-29T09:39:50+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/sammankomster-och-aktiviteter-arrangerade-av-lakemedelsforetag-i-samarbete-med-organisation/2020-04-29T09:40:07+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/sammankomster-och-aktiviteter-arrangerade-av-eller-pa-uppdrag-av-organisation/2020-04-29T09:40:32+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/bakgrund-och-syfte/2026-01-30T09:09:13+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/definitioner/2026-01-30T09:09:20+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/samverkansreglernas-omfattning/2015-11-12T12:19:58+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/barande-principer-och-regler/2019-12-18T15:48:44+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/produktinformation/2026-01-30T09:10:12+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/ovriga-sammankomster/2015-11-12T12:34:38+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/a-sammankomster-arrangerade-av-industrin/2019-12-18T15:49:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/b-sammankomster-gemensamt-arrangerade-av-halso-och-sjukvarden-och-industrin/2019-12-18T15:49:51+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/konsultation-for-industrin/2026-01-30T09:11:04+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/marknadsundersokningar/2019-12-18T15:52:34+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/stipendier/2015-11-12T12:53:20+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/donationer/2015-11-12T12:54:10+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/informations--och-utbildningsmaterial-samt-hjalpmedel/2015-11-12T12:55:43+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/kliniska-provningar/2015-11-12T12:56:32+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/allmanna-forutsattningar/2026-01-30T09:09:25+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/riskminimeringsinformation-rmi---sarskild-information-och-atgarder-i-syfte-att-sakerstalla-korrekt-och-sakert-handhavande-och-funktion/2019-12-18T15:49:07+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/c-sammankomster-arrangerade-av-halso--och-sjukvarden-eller-tredje-part/2026-01-30T09:10:50+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/utvecklingsprojekt-dar-halso--och-sjukvarden-och-lakemedelsforetag-samverkar/2026-01-27T12:01:40+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/patientstodsprogram/2026-01-30T09:11:44+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/tillampliga-regler/2025-09-29T10:06:08+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/definitioner/2025-09-29T10:06:12+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/grundlaggande-principer/2025-09-29T10:06:15+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/2.-lakemedelsinformation-produktinformation2021-06-30T16:03:04+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/3.-ovriga-sammankomster2021-06-30T16:03:11+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/4.-konsultation-och-uppdrag2025-09-29T10:06:24+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/5.-marknadsundersokningar2025-09-29T10:06:29+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/6.-informations--och-utbildningsmaterial-samt-hjalpmedel2020-08-05T11:03:03+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/7.-utvecklingsprojekt2021-06-30T16:03:21+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/definitioner/2015-11-12T13:01:30+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/rapporteringsskyldighetens-omfattning/2015-11-12T13:02:56+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/tidpunkt-for-oppen-rapportering/2015-11-12T13:04:17+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/hur-oppen-rapportering-ska-ske/2015-11-12T13:05:51+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/rapporteringsplattform/2015-11-12T13:08:31+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/tillampligt-regelverk/2015-11-12T13:14:21+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/sprak/2015-11-12T13:15:19+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/dokumentering-och-forvaring-av-uppgifter/2015-11-12T13:15:38+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/individuell-rapportering/2015-11-12T13:16:59+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/aggregerad-rapportering/2015-11-12T13:19:14+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/indirekt-vardeoverforing-till-halso--och-sjukvardspersonal/2015-11-12T13:20:13+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/vardeoverforing-for-forskning-och-utveckling/2015-11-12T13:20:35+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/ytterligare-vagledning/2025-09-29T10:07:50+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/tillampningsomrade-avdelning-2/2025-09-29T10:01:45+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/regler-for-informationens-innehall-och-utformning/2015-11-12T11:33:58+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/saklighet/2015-11-12T11:33:54+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/vederhaftighet/2015-11-12T11:36:59+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/identifierbarhet/2015-11-12T11:39:21+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/aktualitet/2015-11-12T11:44:09+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/dokumentation-och-dess-aberopande/2015-11-12T11:43:59+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/jamforande-information/2015-11-12T11:45:42+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/misskreditering/2015-11-12T11:46:58+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/regler-om-informationens-spridning/2015-11-12T11:49:39+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/sarskilda-regler-for-informationens-utformning/2015-11-12T12:02:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/ansvarsregler/2015-11-12T12:04:22+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/ansvarsbarare/2015-11-12T12:07:18+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/bevisskyldighet/2015-11-12T12:08:14+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/pliktexemplar/2015-11-12T12:09:10+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/tillampningsomrade-avdelning-1/2025-09-29T09:57:19+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/regler-for-informationens-innehall-och-utformning/2015-11-12T11:13:01+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/saklighet/2015-11-12T11:12:10+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/vederhaftighet/2015-11-12T11:12:07+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/identifierbarhet/2016-02-02T16:52:09+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/aktualitet/2015-11-12T11:12:01+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/dokumentation-och-dess-aberopande/2015-11-12T11:11:50+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/jamforande-information/2015-11-12T11:11:33+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/misskreditering/2015-11-12T11:11:25+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/regler-om-informationens-spridning/2015-11-12T11:11:13+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/sarskilda-regler-for-informationens-utformning/2015-11-12T11:10:58+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/lakemedelsprover/2015-11-12T11:10:19+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/ansvarsregler/2015-11-12T11:10:10+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/ansvarsbarare/2015-11-12T11:10:00+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/bevisskyldighet/2015-11-12T11:09:40+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/pliktexemplar/2015-11-12T11:09:24+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-1/2015-11-12T12:57:12+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-2/2016-06-07T13:24:14+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/avdelning-3/2015-11-12T13:01:30+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-1/2025-09-29T09:57:09+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/avdelning-2/2025-09-29T10:01:37+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-1/2021-06-30T09:40:40+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/3/avdelning-2/2016-02-02T17:08:41+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-1/2015-11-12T14:50:13+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/avdelning-2/2015-11-12T14:51:23+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-1/2015-11-12T15:14:04+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-2/2016-12-14T13:41:45+01:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/bilaga-3/2020-10-16T08:50:45+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/om-lifs-valjarundersokning/2025-10-09T05:19:21+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/liberalerna/2025-10-10T02:43:28+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/centerpartiet/2025-10-10T06:39:13+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/kristdemokraterna/2025-10-08T13:47:35+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/miljopartiet/2025-10-10T02:43:31+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/moderaterna/2025-10-10T02:43:33+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/socialdemokraterna/2025-10-10T02:43:36+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/sverigedemokraterna/2025-10-08T16:59:59+02:00weekly0.5https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/vansterpartiet/2025-10-10T02:43:38+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/topplista/2021/de-10-storsta-lakemedelsgrupperna-i-sverige/2022-04-22T12:57:45+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/topplista/2021/topplista-efter-anvandningsomrade/2022-04-22T13:01:34+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/topplista/2021/forsaljningen-for-de-50-storsta-lakemedlen-inkl-parallellhandel-i-sverige-2021/2022-05-12T08:42:58+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/prisindex/2021/lakemedelsprisindex-och-konsumentprisindex/2022-05-20T10:25:39+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/halsorakenskaperna/2020/halsorakenskaperna-och-lakemedelsforsaljningen.-diagram2022-05-16T13:51:11+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/halsorakenskaperna/2020/halsorakenskaperna-och-lakemedelsforsaljningen.-tabell2022-05-16T14:06:38+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/utrikeshandel/2021/sveriges-export-import-och-handelsbalans-av-lakemedel.-linjediagram2022-05-19T09:30:16+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2021/generika-andel-av-den-totala-lakemedelsforsaljningen/2022-03-25T16:02:23+01:00weekly0.5https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2021/original-parallellimport-generika-och-ovrigt-aip/2022-05-19T08:51:44+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2021/original-parallellimport-generika-och-ovrigt-ddd/2022-05-19T08:51:55+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2021/lakemedelsforsaljningen-i-sverige-2000-2020.-linjediagram2022-03-25T15:55:10+01:00weekly0.5https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2021/original-parallellimport-generika-och-ovrigt-2020--aip-och-ddd/2022-04-28T10:09:19+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2021/parallellimport-andel-av-den-totala-lakemedelsforsaljningen-2005-2021.-stapeldiagram2022-09-30T10:17:09+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2021/apotekens-lakemedelsforsaljning-2009-2018/2022-03-30T09:38:35+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2021/receptfria-lakemedelsmarknaden-per-forsaljningssatt/2022-05-19T08:59:43+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2021/apotekens-lakemedelsforsaljning--antal-varurader-humanlakemedel/2022-03-30T09:43:26+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2021/apotekens-totala-lakemedelsforsaljning-per-invanare/2022-03-30T09:49:21+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/betalare/2021/forman-och-egenavgift-for-receptforskrivna-humanlakemedel/2022-03-30T09:59:15+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/betalare/2021/forman-och-egenavgift-for-receptforskrivna-humanlakemedel2/2022-03-30T09:59:42+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/betalare/2021/regionernas-nettokostnad-per-capita-for-halso--och-sjukvard/2022-05-16T14:19:25+02:00weekly0.5https://www.lif.se/statistik/statistikkategorier/betalare/2021/regionernas-nettokostnad-per-capita-for-halso--och-sjukvard.-linjediagram2022-05-16T14:16:37+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/lakemedelsbranschens-etiska-regelverk/omfattning-och-tillamplighet/2025-09-29T09:56:28+02:00weekly0.5https://www.lif.se/etik/etiska-regelverket/innehall/lakemedelsbranschens-etiska-regelverk/bakgrund-och-syfte/2025-09-29T09:56:08+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/alla-i-leveranskedjan-agerar-pa-minsta-avvikelse/2025-10-08T13:33:52+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/utredningen-av-biverkningar-pagar-hela-tiden/2025-10-08T13:34:00+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/malet-ar-en-optimal-behandling-for-varje-enskild-patient/2025-10-08T13:34:00+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/framtidens-provningar-kommer-narmare-patienten/2025-10-08T13:34:00+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/information-och-utbildning-for-saker-lakemedelsanvandning/2025-10-08T13:34:00+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/snabb-relevant-information-om-vara-vacciner-ar-a-och-o/2025-10-08T13:34:00+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/2-600-medarbetare-fran-70-lander-utvecklar-de-nya-lakemedlen/2025-10-08T13:34:01+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/produktionen-pagar-dygnet-runt-hos-pfizer-i-strangnas/2025-10-08T13:34:02+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/extremt-hoga-sakerhetskrav-genomsyrar-bayers-leveranskedja/2025-10-08T13:34:02+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/astrazeneca-i-sodertalje-levererar-produkter-till-miljontals-patienter/2025-10-08T13:34:04+02:00weekly0.5https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/rigorost-arbete-pa-sanofi-for-att-garantera-sakra-lakemedel/2025-10-08T13:34:04+02:00weekly0.5https://www.lif.se/etik/fragor-och-svar/samarbetsdatabasen/samarbeten/2026-06-30T16:25:47+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/samarbetsdatabasen/typ-av-samarbeten/2026-10-12T11:29:35+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2026/lifs-valpodd--vad-vill-sverige/poddavsnitt-1/2026-06-09T10:48:42+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2026/lifs-valpodd--vad-vill-sverige/lifs-valpodd--avsnitt-tva/2026-06-12T09:30:30+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2026/lifs-valpodd--vad-vill-sverige/lifs-valpodd--avsnitt-tre/2026-06-16T09:23:06+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2026/lifs-valpodd--vad-vill-sverige/lifs-valpodd-avsnitt-4/2026-06-17T12:53:50+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2026/lifs-valpodd--vad-vill-sverige/lifs-valpodd--avsnitt-5/2026-06-22T13:19:36+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2026/lifs-valpodd--vad-vill-sverige/lifs-valpodd--almedalen-edition/2026-07-01T08:44:47+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/migran/2025-10-08T13:33:50+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/intervjuerna/2025-10-08T13:33:51+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/masslingen/2025-10-08T13:33:50+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/diabetes/2025-10-08T13:33:50+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/hpv/2025-10-08T13:33:50+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/vaccin/2025-10-08T13:33:50+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/lunginflammation/2025-10-08T13:33:50+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/valfragorna/infor-vaccinationsprogram-for-aldre/2026-01-07T11:34:20+01:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/valfragorna/gron-produktion-av-lakemedel/2026-01-07T11:34:22+01:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/valfragorna/korta-vardkoerna/2026-01-07T11:34:19+01:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/valfragorna/alla-eu-godkanda-lakemedel-ska-kunna-anvandas-i-sverige/2026-01-07T11:39:20+01:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/valfragorna/bekampa-antibiotikaresistensen/2026-01-07T11:34:21+01:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/valfragorna/satsa-pa-life-science/2026-01-07T11:36:32+01:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/valfragorna/dela-halsodata-for-att-utveckla-halso--och-sjukvarden/2026-01-07T11:39:21+01:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/valfragorna/battre-mojligheter-att-delta-i-kliniska-lakemedelsprovningar/2025-10-09T06:36:53+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/partistatistik/kristdemokraterna/2025-10-09T10:45:47+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/partistatistik/socialdemokraterna/2025-10-09T10:45:11+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/partistatistik/moderaterna/2025-10-08T19:25:10+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/partistatistik/sverigedemokraterna/2025-10-08T21:35:54+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/partistatistik/centerpartiet/2025-10-09T10:45:48+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/partistatistik/miljopartiet/2025-10-09T10:36:58+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/partistatistik/vansterpartiet/2025-10-09T10:42:34+02:00weekly0.6https://www.lif.se/fokusomraden/valet-2022/partistatistik/liberalerna/2025-10-09T10:40:06+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/hallbarhet2/lakemedel-och-miljo/2026-01-07T11:34:58+01:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/hallbarhet2/lakemedelsforetagens-arbete-med-de-globala-malen/2025-10-08T13:33:41+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/hallbarhet2/lifs-hallbarhetsmanifest/2026-01-07T11:34:53+01:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/hallbarhet2/fardplan-for-en-fossilfri-lakemedelsbransch/2025-10-08T13:33:38+02:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/hallbarhet2/fardplan-for-fossilfri-konkurrenskraft--innovations--och-kemiindustrierna/2026-01-07T11:34:51+01:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/hallbarhet2/eus-avloppsvattendirektiv/2026-01-07T11:34:55+01:00weekly0.6https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/vaccin/vaccinering-i-sverige/2026-01-07T11:34:59+01:00weekly0.6https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/vaccin/vacciner--sakerhet-och-overvakning/2026-01-07T11:34:53+01:00weekly0.6https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/vaccin/berattelsen-om-vacciner-mot-covid-19/2025-10-08T13:34:15+02:00weekly0.6https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/vaccin/lifs-handlingsplan-for-vaccin/2025-10-08T13:34:14+02:00weekly0.6https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/antibiotikaresistens/sa-kan-du-bidra-i-kampen-mot-antibiotikaresistens/2026-01-07T11:34:38+01:00weekly0.6https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/antibiotikaresistens/utslapp-av-antibiotika-i-miljon/2026-01-07T11:34:34+01:00weekly0.6https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/antibiotikaresistens/lifs-handlingsplan-mot-antibiotikaresistens/2026-01-07T11:34:58+01:00weekly0.6https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/lakemedelsbranschen--en-svensk-basnaring/vardet-av-en-stark-svensk-lakemedelsbransch/2026-05-29T09:53:52+02:00weekly0.6https://www.lif.se/event/_/seminarieserier/forskningens-fantastiska-framsteg/2025-10-10T00:10:30+02:00weekly0.6https://www.lif.se/event/_/seminarieserier/vardens-viktiga-vagval/2025-10-10T00:10:38+02:00weekly0.6https://www.lif.se/event/_/seminarieserier/lifs-eu-valspodd-och-bar/2025-10-10T00:10:53+02:00weekly0.6https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/clinical-trials-day-2022--virtuella-kliniska-provningar/manga-deltagare-i-hjartstudie-tack-vare-app-och-smart-pillerburk/2025-10-09T00:50:40+02:00weekly0.6https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/clinical-trials-day-2022--virtuella-kliniska-provningar/hybridprovning-okar-flexibiliteten-for-bade-patienter-och-halso--och-sjukvarden/2025-10-14T13:29:51+02:00weekly0.6https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/clinical-trials-day-2022--virtuella-kliniska-provningar/pandemin-visade-pa-behovet-av-digitalisering/2025-10-11T03:47:33+02:00weekly0.6https://www.lif.se/sa-funkar-det/lakemedelssakerhet/lakemedelsforetagens-arbete-med-patientsakerhet/nya-tider-staller-nya-krav-pa-arbetet-med-lakemedelssakerhet/2025-10-08T13:34:29+02:00weekly0.6https://www.lif.se/sa-funkar-det/lakemedelssakerhet/lakemedelsforetagens-arbete-med-patientsakerhet/malet-minimalt-med-biverkningar/2025-10-08T13:34:29+02:00weekly0.6https://www.lif.se/sa-funkar-det/lakemedelssakerhet/lakemedelsforetagens-arbete-med-patientsakerhet/kommunikationen-ar-avgorande-for-trygg-lakemedelsanvandning/2025-10-08T13:34:28+02:00weekly0.6https://www.lif.se/lakemedelsstatistik/manadens-forsaljningsstatistik/uppfoljning-av-processerna-for-introduktion-av-nya-lakemedel-i-sverige/metodbeskrivning/2025-12-31T04:30:48+01:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eus-nya-lakemedelslagstiftning/villkor-for-forskning-och-utveckling/2025-10-08T13:34:24+02:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eus-nya-lakemedelslagstiftning/ett-modernt-regelsystem/2025-10-08T13:34:24+02:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eus-nya-lakemedelslagstiftning/atgarder-mot-lakemedelsbrister/2025-10-08T13:34:24+02:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eus-nya-lakemedelslagstiftning/atgarder-mot-antibiotikaresistens-amr/2025-10-08T13:34:24+02:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/valjarstatistik-infor-eu-valet-parti-for-parti/2025-10-09T07:57:36+02:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eu-valet-2024/lifs-eu-valspodd/2025-10-10T00:44:15+02:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/stark-eus-lakemedelsbransch-for-global-konkurrenskraft-och-hallbar-utveckling/2025-10-08T13:34:20+02:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/eu-som-ett-nav-for-innovation-och-forskning/2026-01-07T11:38:07+01:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/satsa-pa-kompetensforsorjning-for-halso--och-sjukvard-och-industri-i-eu/2026-01-07T11:38:10+01:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/en-strategi-for-europeisk-life-science-i-varldsklass/2026-01-07T11:38:10+01:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/se-sjukvard-och-lakemedel-som-en-investering-i-ett-friskare-europa/2026-01-07T11:38:10+01:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/digitalisering-for-battre-sjukvard-och-forskning-i-eu/2026-01-07T11:38:07+01:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/lakemedelsforsorjning-och-god-beredskap-i-europa/2026-01-07T11:38:08+01:00weekly0.6https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/en-hallbar-europeisk-lakemedelsbransch/2026-01-07T11:38:08+01:00weekly0.6https://www.lif.se/nyheter/2024/10/ny-vagledning-starker-genomforandet-av-kliniska-provningar-i-sverige/2025-10-08T22:34:01+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kvalitetsregister/etikoverenskommelsen/2024-12-18T08:17:19+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kvalitetsregister/kvalitetsregister/2024-12-18T08:16:12+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kvalitetsregister/betala-i-forskott/2024-12-18T08:15:24+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kvalitetsregister/utvecklingsprojekt/2024-12-18T08:14:03+01:00weekly0.6https://www.lif.se/statistik/statistikkategorier/topplista/2018/2019-03-26T09:46:00+01:00weekly0.6https://www.lif.se/statistik/statistikkategorier/topplista/2020/2021-03-05T09:49:30+01:00weekly0.6https://www.lif.se/statistik/statistikkategorier/topplista/2021/2022-04-22T12:57:45+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/stipendier-och-donationer/anvandning/2024-12-19T09:32:12+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/stipendier-och-donationer/donationer/2024-12-19T10:34:16+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/upphandling2/ler/2024-12-19T09:31:11+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/monter/2024-12-19T09:30:05+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/kaffe-monter/2024-12-19T09:28:57+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/aktivitet/2024-12-19T09:28:56+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/sjukskoterskor/2024-12-19T09:28:56+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/gavor-monter/2024-12-19T09:28:55+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/vin-monter/2024-12-19T09:28:57+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/monter-lokal/2024-12-19T09:28:55+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/minimiinformation-vepor/2024-12-19T10:45:20+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/far-man-pa-en-internationell-kongress-i-sverige-uppvisa-foretags-pipeline-i-montern/2024-12-19T09:28:54+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/utstallningmonter/fortaring-monter/2024-12-19T09:30:12+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/oppen-rapportering-av-vardeoverforing/oppen-rapportering/2024-12-18T09:01:33+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/oppen-rapportering-av-vardeoverforing/oppenhet/2024-12-18T09:01:38+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/oppen-rapportering-av-vardeoverforing/vardeoverforingar/2024-12-18T09:05:40+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/oppen-rapportering-av-vardeoverforing/information/2024-12-18T08:59:07+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/oppen-rapportering-av-vardeoverforing/samtycke/2024-12-18T08:59:06+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/oppen-rapportering-av-vardeoverforing/annonser/2024-12-18T08:59:05+01:00weekly0.6https://www.lif.se/statistik/statistikkategorier/internationellt/2013/2018-10-02T15:44:19+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/internationellt/2014/2018-10-02T15:44:55+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/internationellt/2016/2020-07-28T10:55:10+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/prisindex/2018/2021-01-21T14:18:57+01:00weekly0.6https://www.lif.se/statistik/statistikkategorier/prisindex/2021/2022-05-16T11:55:43+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/egenvard/2018/2019-05-23T08:59:28+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/utrikeshandel/2018/2020-07-28T08:48:35+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/utrikeshandel/2019/2020-07-28T08:49:02+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/utrikeshandel/2021/2022-05-19T09:28:01+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2015/2018-10-02T15:50:40+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2018/2019-05-23T09:17:52+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2019/2020-08-10T15:53:47+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2020/2021-03-05T10:08:40+01:00weekly0.6https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2021/2022-03-25T15:55:10+01:00weekly0.6https://www.lif.se/statistik/statistikkategorier/halsorakenskaperna/2020/2022-05-16T13:50:11+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/nya-lakemedel/2019/2020-07-28T10:44:09+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/nya-lakemedel/2018/2020-07-28T10:44:09+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/nya-lakemedel/2020/2020-07-28T10:44:09+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/betalare/2107/2018-10-03T10:41:19+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/betalare/2015/2018-10-03T10:41:19+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/betalare/2016/2018-10-03T10:41:19+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/betalare/2018/2019-05-23T09:18:10+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/betalare/2021/2022-03-30T09:59:15+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2015/2018-10-02T14:41:45+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2018/2019-05-23T09:18:15+02:00weekly0.6https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2020/2021-03-05T10:01:07+01:00weekly0.6https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2021/2022-03-30T09:38:35+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/satellitsymposium/2024-12-19T10:23:43+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/julbord/2024-12-19T10:52:22+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/lunch-till-alla/2024-12-19T10:22:22+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/vetenskapligt-mote/2024-12-19T10:51:49+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/sponsring/2024-12-19T10:19:38+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/avbokning/2024-12-19T10:20:07+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/maltid/2024-12-19T10:18:58+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/enskilt-mote/2024-12-19T10:18:25+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/hcp/2024-12-19T10:16:47+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/tredje-part/2024-12-19T10:15:42+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/maltid-utomlands/2024-12-19T10:51:21+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/maltider--fortaring/vin-och-snacks/2024-12-19T10:13:34+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/patienter/2026-07-07T09:18:12+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/sjukvardspersonal/2026-07-07T09:17:51+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/marknadsundersokningsbolag/2026-07-07T09:17:30+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/uppdragsgivare/2026-07-07T09:17:07+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/till-patient/2026-07-07T09:16:32+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/till-medlemmar/2026-07-07T09:16:02+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/forfragan/2026-07-07T09:15:22+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/biverkningar/2026-07-07T09:14:43+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/marknadsundersokningar/ersattning/2026-07-07T09:13:56+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/resor/uppgradera/2024-12-19T10:02:34+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/resor/provarmote/2025-10-02T11:21:08+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/resor/business-class/2024-12-19T10:01:25+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/resor/hcp/2024-12-19T10:28:33+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/enskild-individ/2024-12-19T09:48:59+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/aterbetalningsskyldig/2024-12-19T09:46:41+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/kongressvaskor/2024-12-19T10:33:11+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/budget/2024-12-19T10:33:35+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/tredje-part/2024-12-19T09:48:29+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/sociala-aktiviteter/2024-12-19T10:32:08+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/aktivitet/2024-12-19T10:32:42+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/overskott/2024-12-19T09:43:21+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/verksamhetsomrade/2024-12-19T09:41:46+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/storre-kongress/2024-12-19T09:41:09+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/ej-tillatet/2024-12-19T10:47:22+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/samverkansreglerna/2024-12-19T09:39:46+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/ordinarie-verksamhet/2024-12-19T09:39:15+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/aterbetalning/2024-12-19T09:38:40+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/utbildningsdag/2024-12-19T10:31:05+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/blocka/2024-12-19T09:37:35+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/skillnad-mellan-sponsring-pcos-och-hcos/2024-12-19T10:46:15+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/sponsring/redovisa-annonser/2024-12-19T09:36:20+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/websandning/2024-12-19T10:12:57+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/muntlig-inbjudan/2024-12-19T10:27:22+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/bokningsbrev/2024-12-19T10:12:15+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/selektiv-inbjudan/2024-12-19T10:12:14+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/lakemedelskommiten/2024-12-19T10:12:15+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/studiebesok/2024-12-19T10:12:14+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/ovriga-sammankomster/2024-12-19T10:12:13+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/hotell-och-resa/2024-12-19T10:26:49+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/deltagaravgift/2024-12-19T10:12:12+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/produktinformation--sammankomster/utbildning/2024-12-19T10:12:12+01:00weekly0.6https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-1/2025-10-08T13:44:00+02:00weekly0.6https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-2/2025-10-08T14:21:02+02:00weekly0.6https://www.lif.se/etik/etiska-regelverket/innehall/3/2025-10-08T16:33:21+02:00weekly0.6https://www.lif.se/etik/etiska-regelverket/innehall/kapitel-4/2025-10-08T14:12:11+02:00weekly0.6https://www.lif.se/etik/etiska-regelverket/innehall/bilagor/2025-10-08T15:59:00+02:00weekly0.6https://www.lif.se/etik/etiska-regelverket/innehall/lakemedelsbranschens-etiska-regelverk/2025-10-08T15:19:10+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/konsultation/konsultarvode/2025-10-31T08:56:29+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/konsultation/bonuspoang/2025-10-31T08:56:08+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/konsultation/laserpekare/2025-10-31T08:53:51+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/konsultation/provarmote/2025-10-31T08:54:16+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/konsultation/business-class/2025-10-31T08:55:29+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/konsultation/deltid/2025-10-31T08:54:47+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/konsultation/gava/2025-10-31T08:53:28+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/konsultation/ersattning/2025-10-31T08:52:23+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/sartryck/2025-10-31T08:48:49+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/fact-sheet/2025-10-31T08:47:59+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/minimiinformationen/2025-10-31T08:47:22+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/pressmeddelanden/2025-10-31T08:46:53+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/broschyr/2025-10-31T08:45:39+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/material/2025-10-31T08:48:33+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/paminnelsereklam/2025-10-31T08:46:15+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/pliktexemplar/2025-10-31T08:44:52+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/engelska/2025-10-31T08:39:03+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/banner/2025-10-31T08:43:44+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/uttalande/2025-10-31T08:38:31+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/sjukdomsupplysande-information/2025-10-31T08:37:16+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/andring-spc/2025-10-31T08:36:08+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/forstahandspreparat/2025-10-31T08:34:15+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/instruktionsfilmer/2025-10-03T08:05:18+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/lakemedelsinformation--reklam/material-pa-fass.se2025-10-31T08:32:53+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/utstallning-sjukskoterskor/2026-06-30T13:54:03+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/rx-lakemedel/2026-06-30T13:53:42+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/inbjudan/2026-06-30T13:53:15+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/foretagsrepresentant/2026-06-30T13:52:48+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/sponsring/2026-06-30T13:52:17+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/konsult/2026-06-30T13:51:52+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/konsult-sammankomst/2026-06-30T13:51:11+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/efterkongress/2026-06-30T13:50:39+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/deltagaravgift/2026-06-30T16:24:27+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/satelitsymposium/2026-06-30T13:48:58+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/pliktexemplar-material-internationell-kongress/2026-06-30T13:45:26+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/kongresser/pliktexemplar-inbjudningar-internationell-kongress/2026-06-30T13:46:27+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/inspelning/2026-07-07T09:29:35+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/wikipedia/2026-07-07T09:29:04+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/redigera-wikipedia/2026-07-07T09:28:35+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/dela-i-social-media/2026-07-07T09:27:58+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/facebook/2026-07-07T09:27:26+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/facebook-allmanhet/2026-07-07T09:26:47+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/journalister/2026-07-07T09:26:16+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/blogg/2026-07-07T09:25:45+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/inlagg/2026-07-07T09:25:08+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/youtube/2026-07-07T09:24:32+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/gilla-knapp/2026-07-07T09:24:03+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/app/2026-07-07T09:23:36+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/app-veterinarer/2026-07-07T09:23:00+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/patientapp/2026-07-07T09:22:11+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/naturlakemedel/2026-07-07T09:21:41+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/internet--appar/kliniska-studier/2026-07-07T09:20:44+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/icke-interventionsstudier/kannetecken/2020-08-26T12:33:33+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/icke-interventionsstudier/skillnad/2015-11-12T10:58:17+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/icke-interventionsstudier/avtal/2015-11-12T10:59:14+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/inspelning/2026-07-07T09:09:06+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/delade-tjanster/2026-07-07T09:08:47+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/inbjudningar/2026-07-07T09:08:24+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/huvudman/2026-07-07T09:10:46+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/enskild-individ/2026-07-07T09:04:27+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/godkannande/2026-07-07T09:03:27+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/bokningsbrev/2026-07-07T09:04:09+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/minimiinformation/2026-07-07T09:03:51+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/deltid/2026-07-07T09:10:12+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/ler/2026-07-07T09:06:01+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/selektiv-inbjudan/2026-07-07T09:02:01+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/inbjudan/2026-07-07T09:04:50+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/pliktexemplar/2026-07-07T09:02:29+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/inbjudan-monter/2026-07-07T09:01:30+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/claims/2026-07-07T09:02:59+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/inbjudaninformation-till-huvudman/inbjudan-digitala-moten/2026-07-07T09:02:10+02:00weekly0.6https://www.lif.se/statistik/manadsuppdatering/uppfoljning-av-processerna-for-introduktion-av-nya-lakemedel-i-sverige/Metodbeskrivning/2025-10-10T13:53:40+02:00weekly0.6https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/forskning/foretagsinitierade-kliniska-provningar/2026-09-16T08:43:40+02:00weekly0.6https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/forskning/roster-om-vardet-av-kliniska-provningar/2026-01-07T11:36:59+01:00weekly0.6https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/forskning/hiks--hitta-kliniska-studier/2026-04-10T15:06:08+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/minimiinformationen/2020-08-26T12:39:17+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/hjalpmedel/2015-11-12T10:01:35+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/gransvarde/2015-11-12T10:02:48+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/tryck/2020-08-26T12:38:06+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/hjalpmedel-dyrare-an-450/2015-11-12T10:09:44+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/gavor-ovrig-sammankomst/2015-11-12T10:11:47+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/gavor/2015-11-12T10:16:14+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/gavor-i-monter/2015-11-12T10:18:24+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/laserpekare/2015-11-12T10:31:04+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/material/2015-11-12T10:32:16+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/usb/2015-11-12T10:36:32+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/tryck2/2020-08-26T12:37:30+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/pase/2020-08-26T12:36:27+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/mapp/2020-08-26T12:36:54+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/gavoforbudet/2020-08-26T12:34:54+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/uppvakta-lakare/2015-11-12T10:44:55+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/informstions--och-utbildningsmaterial/2020-08-26T12:38:50+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/kostnad-hjalpmedel/2015-11-12T10:49:24+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/blommavinflaska/2015-11-12T10:51:02+01:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/laromedel/2020-08-05T11:37:22+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/receptblock/2016-10-28T14:31:02+02:00weekly0.6https://www.lif.se/etik/fragor-och-svar/hjalpmedel-material-och-gavor/instruktionsfilmer/2025-10-02T11:06:39+02:00weekly0.6https://www.lif.se/kalendarium/2016/160120-region-skane-inbjuder-till-listdag/2016-03-18T11:22:29+01:00weekly0.7https://www.lif.se/kalendarium/2016/informationsmote-compliance/2016-03-18T11:22:29+01:00weekly0.7https://www.lif.se/kalendarium/2016/161108-lakemedelskongressen-2016/2016-08-19T09:25:22+02:00weekly0.7https://www.lif.se/kalendarium/2016/160315-lakemedelsriksdagen/2016-03-18T11:22:29+01:00weekly0.7https://www.lif.se/kalendarium/2016/160906-nationell-konferens-om-klinisk-forskning/2016-03-18T11:22:29+01:00weekly0.7https://www.lif.se/kalendarium/2016/160510-varmote-om-lakemedel-i-region-ostergotland/2016-03-18T11:22:29+01:00weekly0.7https://www.lif.se/kalendarium/2016/160921-nationella-patientsakerhetskonferensen-2016/2016-03-18T11:25:03+01:00weekly0.7https://www.lif.se/kalendarium/2016/160518-seminarium-ratt-behandling-till-ratt-patient--sa-sakrar-vi-evidens-och-kostnadseffektivitet/2016-04-13T16:09:35+02:00weekly0.7https://www.lif.se/kalendarium/2016/160511-lif-juristmote/2016-04-29T10:45:59+02:00weekly0.7https://www.lif.se/kalendarium/2016/160512-produktiviteten-i-svensk-akutsjukhusvard-i-ett-internationellt-perspektiv/2016-04-26T16:37:08+02:00weekly0.7https://www.lif.se/kalendarium/2016/160929-samverkansdagen-2016-en-ny-niva-av-ordning-och-reda/2016-08-23T09:13:40+02:00weekly0.7https://www.lif.se/kalendarium/2016/161118-lakemedelsmarknadsdagen/2016-08-23T09:17:59+02:00weekly0.7https://www.lif.se/kalendarium/2016/161216-seminarium---presentation-av-sbu-nls-uppdrag/2016-10-07T10:46:54+02:00weekly0.7https://www.lif.se/kalendarium/2016/161116-lifs-juristmote/2016-10-14T13:50:26+02:00weekly0.7https://www.lif.se/kalendarium/2015/ima-kurs/2015-09-09T12:16:57+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-dagens-medicin/2015-09-09T11:56:43+02:00weekly0.7https://www.lif.se/kalendarium/2015/seminarium-patientmaktsutredningen/2015-09-09T12:16:41+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-blanck-deltar-under-varldscancerdagen/2015-09-09T12:17:24+02:00weekly0.7https://www.lif.se/kalendarium/2015/ima-kurs---uppdatering/2015-09-09T12:18:44+02:00weekly0.7https://www.lif.se/kalendarium/2015/temadag--reklamationer--indragningar/2015-09-09T12:18:31+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-blanck-forelaser-pa-lakemedelsriksdagen/2015-09-09T12:17:38+02:00weekly0.7https://www.lif.se/kalendarium/2015/agenda-for-halsa-och-valstand/2015-09-09T12:20:15+02:00weekly0.7https://www.lif.se/kalendarium/2015/sallsynta-dagen-2015/2015-09-09T12:17:59+02:00weekly0.7https://www.lif.se/kalendarium/2015/konferens-om-nordiskt-samarbete-runt-kliniska-provningar/2015-09-09T12:23:26+02:00weekly0.7https://www.lif.se/kalendarium/2015/nls-days/2015-09-09T12:15:29+02:00weekly0.7https://www.lif.se/kalendarium/2015/lif-ar-samarbetspartner-till-biobanksutbildning/2015-09-09T12:24:36+02:00weekly0.7https://www.lif.se/kalendarium/2015/kommissionen-for-jamlik-vard-presenterar-sin-slutrapport/2015-09-09T12:18:20+02:00weekly0.7https://www.lif.se/kalendarium/2015/nationell-konferens-om-klinisk-forskning/2015-09-09T12:25:55+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-blanck-deltar-i-paneldebatt-under-lakemedelsverkets-25-arsdag/2015-09-09T12:20:43+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-blanck-delar-i-panel-om-sarlakemedel/2015-09-09T12:29:20+02:00weekly0.7https://www.lif.se/kalendarium/2015/life-science-dagen-2015/2015-09-09T12:24:48+02:00weekly0.7https://www.lif.se/kalendarium/2015/karolina-antonov-deltar-i-seminarium-om-innovationsupphandling-inom-lakemedelsomradetny-sida/2015-09-09T12:23:15+02:00weekly0.7https://www.lif.se/kalendarium/2015/lifs-juristmote/2015-09-09T12:24:59+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-blanck-deltar-i-seminarium-under-lakemedelsdagen-2015/2015-09-09T12:20:56+02:00weekly0.7https://www.lif.se/kalendarium/2015/lakemedelskongressen-2015/2015-09-09T12:25:34+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-blanck-haller-seminarium-om-framtidens-utmaningar-for-svensk-sjukvard-lakemedelsindustri-och-patient/2015-09-09T12:21:24+02:00weekly0.7https://www.lif.se/kalendarium/2015/grundlaggande-utbildning-i-farmakologi/2015-09-09T12:22:50+02:00weekly0.7https://www.lif.se/kalendarium/2015/riksstamman-2015/2015-11-02T13:21:35+01:00weekly0.7https://www.lif.se/kalendarium/2015/a-world-without-antibiotics-uppsala-health-summit-2015/2015-09-09T12:19:57+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-blanck-deltar-i-arets-ihe-forum/2015-09-09T12:21:08+02:00weekly0.7https://www.lif.se/kalendarium/2015/lungcancer---fran-dodsdom-till-framtidshopp/2015-09-09T12:25:10+02:00weekly0.7https://www.lif.se/kalendarium/2015/vaccinationer-raddar-liv--men-vem--tanker-pa-det/2015-09-09T12:26:31+02:00weekly0.7https://www.lif.se/kalendarium/2015/anders-blanck-och-helene-hellmark-knutsson-i-morgon-tv/2015-09-09T12:21:39+02:00weekly0.7https://www.lif.se/kalendarium/2015/myter-om-jamlik-vard-och-personcentrerad-vard/2015-09-09T12:25:45+02:00weekly0.7https://www.lif.se/kalendarium/2015/jamlik-halsa-vardebaserad-vard-eller-satsning-pa-e-halsa--vilken-blir-arets-stora-vardfraga/2015-09-09T12:23:03+02:00weekly0.7https://www.lif.se/kalendarium/2015/framgangsfaktorer-for-en-levande-life-science-nation/2015-09-09T12:22:04+02:00weekly0.7https://www.lif.se/kalendarium/2015/varldsledande-inom-life-science--strategierna-finns-dags-for-verkstad/2015-09-09T12:26:55+02:00weekly0.7https://www.lif.se/kalendarium/2015/svensk-sjukvard--en-bit-kvar-till-varldsklass/2015-09-09T12:26:21+02:00weekly0.7https://www.lif.se/kalendarium/2015/langsam-introduktion-av-nya-lakemedel---vems-ansvar/2015-09-09T12:25:22+02:00weekly0.7https://www.lif.se/kalendarium/2015/varfor-far-svenskar-inte-lika-moderna-behandlingar-som-befolkningen-i-spanien-och-frankrike/2015-09-09T12:26:44+02:00weekly0.7https://www.lif.se/kalendarium/2015/nul-seminarium/2015-09-10T14:33:35+02:00weekly0.7https://www.lif.se/kalendarium/2015/forskarfredag/2015-09-09T12:21:50+02:00weekly0.7https://www.lif.se/kalendarium/2015/lif-deltar-under-lakemedelsmarknadsdagen-2015/2015-09-09T12:23:37+02:00weekly0.7https://www.lif.se/kalendarium/2015/patientens-val-i-fokus---kan-vardvalet-ske-utifran-medicinska-behandlingsresultat/2015-10-13T09:08:41+02:00weekly0.7https://www.lif.se/kalendarium/2015/gemensam-standard-for-lakemedel-och-medicinteknik-diskuteras-under-e-halsodagen-2015/2015-09-09T12:15:45+02:00weekly0.7https://www.lif.se/kalendarium/2015/151013-anders-blanck-deltar-i-sns-seminarium-om-introduktion-av-nya-lakemedel/2015-09-17T14:36:59+02:00weekly0.7https://www.lif.se/kalendarium/2015/151110-frukostseminarium-om-svensk-sjukvard-i-internationellt-perspektiv/2015-09-17T15:11:53+02:00weekly0.7https://www.lif.se/kalendarium/2015/151021-lif-deltar-under-lakemedelsmarknadsdagen-2015/2015-09-29T08:45:11+02:00weekly0.7https://www.lif.se/kalendarium/2015/mingelseminarium-akademi--naringsliv--sjukvard-incitament-och-barriarer-for-samverkan/2015-11-30T07:59:16+01:00weekly0.7https://www.lif.se/kalendarium/2015/151216-frukostmote-om-arets-va-barometer/2015-11-09T14:31:56+01:00weekly0.7https://www.lif.se/kalendarium/2015/151202-jonas-vikman-deltar-i-panel-om-svensk-vardexport/2015-11-10T15:31:42+01:00weekly0.7https://www.lif.se/kalendarium/2015/151126-it-i-varden-priset-delas-ut/2015-11-18T15:12:27+01:00weekly0.7https://www.lif.se/kalendarium/2018/180118-skanelistan-2018/2018-05-15T13:13:42+02:00weekly0.7https://www.lif.se/kalendarium/2018/180207-vision-2025-lakemedel-i-miljon-ar-inte-langre-ett-problem.-hur-vill-vi-gora2018-05-15T13:13:42+02:00weekly0.7https://www.lif.se/kalendarium/2018/180323-landstingens-lakemedelsstrategier-2018-vardefullt-men-kostsamt---vad-gor-man-nar-pengarna-inte-racker-till/2018-05-15T13:13:42+02:00weekly0.7https://www.lif.se/kalendarium/2018/180204-varldscancerdagen-2018/2018-05-15T13:13:42+02:00weekly0.7https://www.lif.se/kalendarium/2018/180406-natverksmote-pharma-meets-e-health-ii/2018-05-15T13:13:42+02:00weekly0.7https://www.lif.se/kalendarium/2018/180508-lifs-juristmote/2018-05-15T13:13:42+02:00weekly0.7https://www.lif.se/kalendarium/2018/180912-motesplats-lakemedel/2018-05-15T13:13:42+02:00weekly0.7https://www.lif.se/kalendarium/2018/180906-07-ihe-forum/2018-05-16T09:21:34+02:00weekly0.7https://www.lif.se/kalendarium/2018/180926-fran-patent-till-patient/2018-09-24T15:08:24+02:00weekly0.7https://www.lif.se/kalendarium/2018/180829-politisk-framtidsdiskussion/2018-08-20T16:26:37+02:00weekly0.7https://www.lif.se/kalendarium/2018/180912-breakfast-seminar/2018-09-07T13:52:19+02:00weekly0.7https://www.lif.se/kalendarium/2018/cancerdagen-2018/2018-09-11T09:33:17+02:00weekly0.7https://www.lif.se/kalendarium/2018/181121-medinnovation-skane-2018/2018-10-18T11:43:49+02:00weekly0.7https://www.lif.se/kalendarium/2018/181129-serialisering-och-sakerhetsforsegling/2018-10-18T11:51:10+02:00weekly0.7https://www.lif.se/kalendarium/2018/lakemedelsmarknadsdagen-2018/2018-11-21T09:38:05+01:00weekly0.7https://www.lif.se/kalendarium/2018/181212-pharma-outsourcing-2018/2018-11-22T11:04:23+01:00weekly0.7https://www.lif.se/kalendarium/2018/181130-infuturum-2018/2018-11-27T14:24:15+01:00weekly0.7https://www.lif.se/kalendarium/2018/181207-lhc-dagen/2018-11-29T11:17:45+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/topplista/2025-12-30T06:26:03+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/utrikeshandel/2025-12-30T15:35:19+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/lakemedelsforetagens-forsaljning/2025-12-30T16:10:36+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/nya-lakemedel/2025-12-30T05:31:58+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/betalare/2025-12-29T21:30:38+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/apotekens-forsaljning/2025-12-29T20:04:13+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/forskning-och-utveckling/2025-12-31T02:48:15+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/internationellt/2025-12-30T01:20:27+01:00weekly0.7https://www.lif.se/statistik/statistikkategorier/prisindex/2025-12-30T05:40:57+01:00weekly0.7https://www.lif.se/kalendarium/2017/170321-lakemedelsriksdagen/2017-04-27T09:05:22+02:00weekly0.7https://www.lif.se/kalendarium/2017/varldscancerdagen-2017/2017-04-27T09:05:22+02:00weekly0.7https://www.lif.se/kalendarium/2017/171026-nul-seminarium/2017-09-25T08:48:17+02:00weekly0.7https://www.lif.se/kalendarium/2017/lakemedelskongressen-2017/2017-05-16T09:00:44+02:00weekly0.7https://www.lif.se/kalendarium/2017/myihealth---ny-stor-konferens-i-stockholm-20-21-sep/2017-04-27T09:05:22+02:00weekly0.7https://www.lif.se/kalendarium/2017/nationell-konferens-om-kliniska-studier-2017/2017-04-27T09:05:22+02:00weekly0.7https://www.lif.se/kalendarium/2017/170821-22-anders-blanck-deltar-i-livsplats-sverige/2017-05-10T10:59:36+02:00weekly0.7https://www.lif.se/kalendarium/2017/170907-08-karolina-antonov-deltar-i-ihe-forum-2017/2017-05-12T16:44:04+02:00weekly0.7https://www.lif.se/kalendarium/2017/171004-anders-blanck-deltar-i-debatt-om-hur-kunskap-kring-lakemedel-kan-forbattras-och-samarbete-underlattas/2017-05-29T12:50:55+02:00weekly0.7https://www.lif.se/kalendarium/2017/170824-informationsmote-om-eu-forordningen-kliniska-provningar-och-det-svenska-pilotforfarandet/2017-06-22T09:55:55+02:00weekly0.7https://www.lif.se/kalendarium/2017/170926-motesplats-lakemedel/2017-08-23T10:06:15+02:00weekly0.7https://www.lif.se/kalendarium/2017/171114-informationsmote-om-e-verifikation/2017-09-29T14:47:05+02:00weekly0.7https://www.lif.se/kalendarium/2017/171128-lif-juristmote/2017-10-13T10:35:30+02:00weekly0.7https://www.lif.se/kalendarium/2017/171211-how-can-your-company-benefit-from-ceta/2017-11-08T13:01:47+01:00weekly0.7https://www.lif.se/kalendarium/2017/171113-natverksmote-pharma-meets-e-health/2017-11-08T13:08:04+01:00weekly0.7https://www.lif.se/kalendarium/2017/171129-medinnovation-skane-2017/2017-11-15T09:14:52+01:00weekly0.7https://www.lif.se/kalendarium/2017/171122-lunchseminarium-teknologi-och-patientcentrerad-cancervard/2017-11-15T13:13:09+01:00weekly0.7https://www.lif.se/kalendarium/2020/200130-skanelistan-2020/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/200115-informationsmote-r-rct-registerbased-randomised-clinical-trial/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-02-12-14e-nationella-natverkskonferensen-2020/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-02-03-nationella-cancerstrategin-10-ar/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-05-12-varmote-om-lakemedel-i-region-ostergotland/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-09-22-samverkansdag-forutsattningar-och-mojligheter--forskning-utveckling-och-innovation-baserad-pa-kvalitetsregister-och-patientoversikter-inom-cancervarden/2020-09-11T19:01:33+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-09-10-motesplats-lakemedel/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-09-14-vardens-viktiga-vagval-1-ska-varden-flytta-in-eller-ut/2020-09-14T08:21:29+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-10-14-vardens-viktiga-vagval-2-vagen-till-en-digitaliserad-halso--och-sjukvard/2025-10-08T20:22:13+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-11-16-vardens-viktiga-vagval-3-vagen-till-en-kunskapsstyrd-halso--och-sjukvard/2025-10-11T19:40:10+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-05-27-webbinar-hur-sakerstaller-vi-lakemedel-till-covid-19-patienterna/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-06-11-webbinar-vaccin-mot-coronavirus/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-06-17-ar-covid-19-pandemin-dodsstoten-for-svensk-klinisk-cancerforskning/2020-06-05T14:31:32+02:00weekly0.7https://www.lif.se/kalendarium/2020/every-day-counts.-accelerate-access.-beat-cancer2020-08-10T09:07:38+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-11-25-vastsverige-och-den-nya-nationella-life-sciencestrategin/2020-10-05T10:17:39+02:00weekly0.7https://www.lif.se/kalendarium/2020/digital-utbildningsdag-den-6e-november-2020-den-virtuella-framtiden--hur-paverkas-kliniska-provningar/2020-10-09T11:07:01+02:00weekly0.7https://www.lif.se/kalendarium/2020/2020-11-23-lakemedelsbranschen-och-de-globala-hallbarhetsmalen--sa-bidrar-vi-till-att-realisera-agenda-2030/2020-11-23T07:52:16+01:00weekly0.7https://www.lif.se/kalendarium/2020/2020-10-19-i-skuggan-av-covid-19-antibiotikakrisen-och-vara-beteenden/2020-10-13T08:50:42+02:00weekly0.7https://www.lif.se/kalendarium/2020/betalningsmodeller-for-atmp--vad-hander/2020-11-06T10:42:05+01:00weekly0.7https://www.lif.se/kalendarium/2020/2020-12-10-pharma-outsourcing-2020/2020-11-26T08:28:01+01:00weekly0.7https://www.lif.se/kalendarium/2019/190206-06-nationell-konferens-om-kliniska-studier/2019-02-19T08:59:35+01:00weekly0.7https://www.lif.se/kalendarium/2019/190326/2019-02-19T09:00:00+01:00weekly0.7https://www.lif.se/kalendarium/2019/190125-prissattning-och-finansiering-av-lakemedel/2019-02-19T08:58:58+01:00weekly0.7https://www.lif.se/kalendarium/2019/lakemedelsforskning--en-sjalvklar-del-av-svensk-sjukvard/2019-03-04T13:23:04+01:00weekly0.7https://www.lif.se/kalendarium/2019/190322-open-health-economic-method-seminar/2019-03-12T12:41:53+01:00weekly0.7https://www.lif.se/kalendarium/2019/191119-21-10e-nationella-prioriteringskonferensen/2019-02-25T08:42:31+01:00weekly0.7https://www.lif.se/kalendarium/2019/190529-dn-konferens-life-science/2019-03-05T17:08:18+01:00weekly0.7https://www.lif.se/kalendarium/2019/motesplats-Lakemedel-2019/2019-03-20T13:23:29+01:00weekly0.7https://www.lif.se/kalendarium/2019/190423-vem-ager-vad-immaterialrattsforvarv-och-relationernas-betydelse/2019-03-27T16:31:51+01:00weekly0.7https://www.lif.se/kalendarium/2019/190510-atmp--halsoekonomi-och-vardens-ekonomi/2019-04-24T08:33:17+02:00weekly0.7https://www.lif.se/kalendarium/2019/190927-myelomdagen-2019/2019-04-11T11:05:02+02:00weekly0.7https://www.lif.se/kalendarium/2019/190829-nya-lakemedel-i-en-foranderlig-varld/2019-08-14T15:02:40+02:00weekly0.7https://www.lif.se/kalendarium/2019/190905-06-ihe-forum-2019/2019-05-06T12:35:15+02:00weekly0.7https://www.lif.se/kalendarium/2019/190610-vima-kurs/2019-04-26T16:23:13+02:00weekly0.7https://www.lif.se/kalendarium/2019/190521-23-vitalis-2019/2019-05-06T12:34:50+02:00weekly0.7https://www.lif.se/kalendarium/2019/brown-bag-lunch-talk-infor-eu-valet/2019-05-10T15:04:05+02:00weekly0.7https://www.lif.se/kalendarium/2019/190529-gms-industry-collaboration-meet-and-greet-gms-event/2019-05-17T09:43:56+02:00weekly0.7https://www.lif.se/kalendarium/2019/191210-pharma-outsourcing---find-the-right-partner/2019-06-05T11:34:38+02:00weekly0.7https://www.lif.se/kalendarium/2019/190822-det-goda-livet--almedalens-efterdebatt-sker-i-goteborg/2019-07-05T15:44:24+02:00weekly0.7https://www.lif.se/kalendarium/2019/191118-19-7th-conference-on-clinical-trials--in-the-nordic-countries-2019/2019-06-19T13:40:16+02:00weekly0.7https://www.lif.se/kalendarium/2019/190927-nya-riktlinjer-for-ivd-i-kliniska-lakemedelsprovningar/2019-09-24T09:09:09+02:00weekly0.7https://www.lif.se/kalendarium/2019/how-to-make-europe-the-global-leader-in-smart-health/2019-09-02T16:05:23+02:00weekly0.7https://www.lif.se/kalendarium/2019/191203-medinnovation-i-skane/2019-10-10T16:28:56+02:00weekly0.7https://www.lif.se/kalendarium/2019/191115-oppet-projektmote-atmp-affarsmodeller-och-halsoekonomi/2019-10-21T09:59:52+02:00weekly0.7https://www.lif.se/kalendarium/2019/191211-modern-och-framtida-vard---genterapi/2019-11-12T10:02:06+01:00weekly0.7https://www.lif.se/kalendarium/2019/191121-frukostklubben-har-sverige-verkligen-dyrare-lakemedel-an-andra-lander/2019-11-14T11:53:44+01:00weekly0.7https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/eus-nya-lakemedelslagstiftning/2025-11-12T11:15:28+01:00weekly0.7https://www.lif.se/fokusomraden/life-science-och-lakemedel-i-eu2/reformagenda-for-eu/2025-10-08T13:34:21+02:00weekly0.7https://www.lif.se/fokusomraden/valet-2022/om-lifs-valjarundersokning/2025-10-09T04:10:56+02:00weekly0.7https://www.lif.se/fokusomraden/valet-2022/valfragorna/2025-10-08T15:58:53+02:00weekly0.7https://www.lif.se/fokusomraden/valet-2022/partistatistik/2025-10-08T17:27:16+02:00weekly0.7https://www.lif.se/fokusomraden/valet-2022/valjarna--valet/2025-10-09T02:58:00+02:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/lakemedelsforsorjning/2026-01-07T11:36:52+01:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/tillgang-till-nya-lakemedel/2026-05-19T10:03:00+02:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/vaccin/2025-10-08T13:34:13+02:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/egenvard/2026-07-13T08:45:53+02:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/precisionsmedicin/2025-10-08T13:34:13+02:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/antibiotikaresistens/2025-10-08T13:34:05+02:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/patientsamverkan/2026-10-01T10:26:17+02:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/kombinationsbehandlingar/2026-01-07T11:39:29+01:00weekly0.7https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/lakemedel-och-sjukvardens-kapacitet/2026-09-28T15:20:36+02:00weekly0.7https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/forskning/2026-09-28T15:30:12+02:00weekly0.7https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/dagens-forskning--framtidens-medicin/2026-09-28T15:25:08+02:00weekly0.7https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/immateriella-tillgangar-och-rattigheter/2026-03-04T08:59:02+01:00weekly0.7https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/halsodata/2026-09-28T15:38:30+02:00weekly0.7https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/en-fraga-om-liv-och-dod/2025-10-08T13:33:26+02:00weekly0.7https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/hallbarhet2/2025-10-08T13:33:37+02:00weekly0.7https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/lakemedelsbranschen--en-svensk-basnaring/2026-09-28T07:25:38+02:00weekly0.7https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/vad-vill-sverige/2026-08-25T16:06:21+02:00weekly0.7https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/lakemedel-och-beredskap/2026-05-15T07:15:58+02:00weekly0.7https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/lakemedel-och-svensk-tillvaxt/2026-07-07T10:37:43+02:00weekly0.7https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/most-favored-nation/2026-06-29T14:23:28+02:00weekly0.7https://www.lif.se/event/_/seminarieserier/2025-10-10T00:10:18+02:00weekly0.7https://www.lif.se/kalendarium/2022/2022-03-08-nordic-biobank-conference-2022/2022-01-17T08:55:30+01:00weekly0.7https://www.lif.se/kalendarium/2022/vardens-viktiga-vagval-antibiotikautmaningen/2025-10-11T14:13:37+02:00weekly0.7https://www.lif.se/kalendarium/2022/vardens-viktiga-vagval-halsodata/2025-10-16T23:04:17+02:00weekly0.7https://www.lif.se/kalendarium/2022/vardens-viktiga-vagval-precisionsmedicin/2025-10-10T06:02:23+02:00weekly0.7https://www.lif.se/kalendarium/2022/nationell-life-science-konferens/2025-10-16T03:11:44+02:00weekly0.7https://www.lif.se/kalendarium/2022/online-kick-off-amr-innovation-mission-sweden-2022/2025-10-11T21:21:52+02:00weekly0.7https://www.lif.se/kalendarium/2022/forskningens-fantastiska-framsteg-reumatism/2025-10-08T14:45:20+02:00weekly0.7https://www.lif.se/kalendarium/2022/varmotet-i-region-ostergotland-11-maj-2022/2025-10-17T04:47:22+02:00weekly0.7https://www.lif.se/kalendarium/2021/industridagenskanelistan-2021/2021-11-10T11:13:29+01:00weekly0.7https://www.lif.se/kalendarium/2021/2021-02-24-vardens-viktiga-vagval-5---forandrade-forutsattningar-for-den-patientnara-forskningen--utmaningar-och-mojligheter-for-svensk-life-science/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-01-21-vardens-viktiga-vagval-4---hur-kan-prevention-starka-folkhalsan-och-pa-sikt-minska-sjukvardens-kostnader/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-03-24-vardens-viktiga-vagval-6---fortbildning-och-kompetensutveckling--vagen-framat/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-04-22-vardens-viktiga-vagval-7---tema-precisionsmedicin/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/nationell-life-science-konferens/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-01-26-for-var-overlevnad---rent-vatten-och-vaccin/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-02-04-pa-troskeln-till-den-nya-cancervarden/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-02-04-varldscancerdagen-4-februari-2021/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-04-26-30-conference-atmp-world-tour-2021--join-us-in-a-virtual-trip-around-the-world-to-highlight-world-leading-activities-in-atmp/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2121-03-23-swecarnets-utbildningsdag-for-car-t/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-02-17-tlv-att-utveckla-halsoekonomiska-bedomningar-for-precisionsmedicin--och-utreda-mojliga-betalningsmodeller-for-atmp/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-03-09-frukostmote-hur-blir-vi-bast-pa-e-halsa-i-saval-teori-som-praktik/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/varmotet-om-lakemedel-i-region-ostergotland/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/motesplats-lakemedel-2021/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-03-18-nordic-life-science-meeting--nordic-life-science-collaboration-for-stronger-competitiveness/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-03-16-inbjudan-governance-i-och-effekter-av-innovationssatsningar/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-05-04-pharmaceuticals--medical-devices-combined/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-03-24-ett-innovativt-mindre-life-scienceforetags-framgangsrecept--en-bra-ide-blandad-med-stark-innovationskraft-och-erfarenhet/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/21-03-24-sekundaranvandning-av-vard--och-halsodata--for-forskning-innovation-och-beslutsfattande--del-1-av-2-konferenser-pa-amnet/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-04-14-far-vi-i-sverige-ta-del-av-nya-innovativa-lakemedel/2021-04-20T14:19:39+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-05-18-vardens-viktiga-vagval-8--hur-gar-det-for-den-svenska-cancerstrategin-i-skuggan-av-pandemin/2021-04-29T13:23:43+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-09-08-vardens-viktiga-vagval-9---hur-kan-den-psykisk-ohalsan-minska/2021-09-03T08:30:11+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-10-06-vardens-viktiga-vagval-10---ar-det-dags-for-en-svensk-strategi-for-sallsynta-sjukdomar/2021-10-01T15:53:05+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-11-11-vardens-viktiga-vagval-11---hur-ska-varden-av-de-aldre-se-ut-i-framtiden/2021-10-29T11:17:34+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-05-27-hur-star-det-till-med-e-halsan-i-sverige/2021-05-21T10:56:15+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-05-25-stockholm-life-science-conference-2021/2021-04-23T14:08:51+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-05-11-strokevardens-framsteg-och-framtid/2021-05-07T09:46:43+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-06-02-chatbots-i-varden--framtid-eller-samtid-mojlighet-eller-hot/2021-05-24T12:07:16+02:00weekly0.7https://www.lif.se/kalendarium/2021/fler-foretagsinitierade-kliniska-provningar-till-sverige/2021-05-18T16:17:11+02:00weekly0.7https://www.lif.se/kalendarium/2021/vardens-viktiga-vagval-valspecial--1-ar-kvar-till-valet/2021-10-06T13:25:21+02:00weekly0.7https://www.lif.se/kalendarium/2021/forskningens-fantastiska-framsteg-migran/2021-09-22T07:41:26+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-06-22-sa-far-sverige-fler-kliniska-provningar/2021-06-22T10:11:41+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-07-05-sa-far-sverige-fler-foretagsinitierade-kliniska-lakemedelsprovningar/2021-06-30T17:04:07+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-07-06-sa-accelererar-vi-implementeringen-av-precisionsmedicin/2021-07-01T11:27:32+02:00weekly0.7https://www.lif.se/kalendarium/2021/forskningens-fantastiska-framsteg-diabetes/2021-11-12T11:33:37+01:00weekly0.7https://www.lif.se/kalendarium/2021/forskningens-fantastiska-framsteg-hpv/2025-10-08T18:59:43+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-09-17-frukostmote-blockkedjeteknik/2021-09-07T15:46:02+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-09-02-the-future-of-swedish-and-danish-life-science/2021-08-31T13:02:33+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-09-07-the-future-of-rare-diseases-in-europe/2021-08-31T16:06:53+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-10-22-frukostmote-implementering-av-digitala-losningar-i-varden-utmaningar-och-drivkrafter/2021-10-14T12:41:26+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-11-18-ivdr-summit/2021-10-26T16:12:07+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-10-20-framtidens-halsa-kliniska-provningar---fran-patientens-och-vardens-perspektiv/2021-10-14T12:41:14+02:00weekly0.7https://www.lif.se/kalendarium/2021/dagar-om-lagar-2021---tva-dagar-om-halsodata-och-molntjanster/2021-10-21T12:02:17+02:00weekly0.7https://www.lif.se/kalendarium/2021/nordic-baltic-hta-forum--whats-happening-nationally-regionally-and-in-eu/2021-10-26T16:17:54+02:00weekly0.7https://www.lif.se/kalendarium/2021/hand-i-hand-for-framtidens-forskning--forskningspersonal-och-patient-i-fokus/2021-10-26T16:17:03+02:00weekly0.7https://www.lif.se/kalendarium/2021/2021-11-12-how-can-scilifelab-max-iv-and-ess-contribute-to-drug-discovery-and-development/2021-11-05T10:51:34+01:00weekly0.7https://www.lif.se/kalendarium/2021/2021-11-25-lakemedelsbranschen-och-de-globala-hallbarhetsmalen--nasta-steg/2021-11-22T17:48:49+01:00weekly0.7https://www.lif.se/kalendarium/2021/2021-11-24-precisionshalsa--vad-ar-nyttan-for-invanarna-och-samhallet/2021-11-22T18:04:10+01:00weekly0.7https://www.lif.se/kalendarium/2021/2021-12-06-folkhalsodalen/2021-11-29T12:47:40+01:00weekly0.7https://www.lif.se/sa-funkar-det/lakemedelssakerhet/patientsakerhet-kraver-samarbete/2025-10-08T13:34:30+02:00weekly0.7https://www.lif.se/sa-funkar-det/lakemedelssakerhet/lakemedelsforetagens-arbete-med-patientsakerhet/2025-10-08T13:34:28+02:00weekly0.7https://www.lif.se/fokusomraden/lif-i-almedalen-2026/lifs-experters-medverkan-i-almedalen/2026-06-16T02:46:03+02:00weekly0.7https://www.lif.se/fokusomraden/lif-i-almedalen-2026/lifs-medlemmars-seminarier/2026-06-23T15:42:09+02:00weekly0.7https://www.lif.se/fokusomraden/lif-i-almedalen-2026/life-science-arena/2026-06-22T13:27:09+02:00weekly0.7https://www.lif.se/fokusomraden/lif-i-almedalen-2026/lifs-seminarier-i-almedalen/2026-06-16T15:31:51+02:00weekly0.7https://www.lif.se/fokusomraden/poddserien-kvartetten/kvartetten--avsnitt-1/2026-09-14T10:49:40+02:00weekly0.7https://www.lif.se/fokusomraden/valet-2026/partienkat-om-lakemedelspolitik/2026-09-07T12:11:52+02:00weekly0.7https://www.lif.se/om-lif/karriar-pa-lif/lediga-tjanster/2026-04-15T17:15:14+02:00weekly0.7https://www.lif.se/etik/fragor-och-svar/2025-10-08T13:34:58+02:00weekly0.8https://www.lif.se/etik/etiska-regelverket/2026-01-30T09:06:41+01:00weekly0.8https://www.lif.se/etik/compliance/2024-12-03T11:07:43+01:00weekly0.8https://www.lif.se/etik/samarbetsdatabaser/2026-05-22T08:52:43+02:00weekly0.8https://www.lif.se/etik/forhandsgodkanda/2026-04-21T07:51:21+02:00weekly0.8https://www.lif.se/etik/ign-och-nbl/2026-08-21T15:02:06+02:00weekly0.8https://www.lif.se/etik/oppen-rapportering-av-vardeoverforingar/2026-10-13T09:45:06+02:00weekly0.8https://www.lif.se/etik/branschutbildningar/2025-10-08T13:34:57+02:00weekly0.8https://www.lif.se/etik/e-utbildning-om-samverkan-mellan-lakemedelsforetag-patientorganisationer-och-patienter/2025-10-08T13:34:57+02:00weekly0.8https://www.lif.se/etik/dokument-och-mallar-for-omradet-etik/2026-08-14T11:55:48+02:00weekly0.8https://www.lif.se/etik/vardeoverforing/2025-07-02T08:24:47+02:00weekly0.8https://www.lif.se/fokusomraden/varldsledande-forskning-och-utveckling/2025-10-08T13:34:15+02:00weekly0.8https://www.lif.se/fokusomraden/en-aktiv-och-hallbar-samhallsaktor/2025-10-08T13:33:37+02:00weekly0.8https://www.lif.se/fokusomraden/effektiva-lakemedel-och-en-modern-sjukvard/2026-04-17T10:41:32+02:00weekly0.8https://www.lif.se/fokusomraden/valet-2026/2026-09-10T09:51:32+02:00weekly0.8https://www.lif.se/fokusomraden/poddserien-kvartetten/2026-09-14T10:49:36+02:00weekly0.8https://www.lif.se/material-och-dokument/ladda-ned-dokument-avtal-och-mallar/2025-10-08T13:34:59+02:00weekly0.8https://www.lif.se/material-och-dokument/Bestalla-och-ladda-ner-material/2025-10-17T08:27:21+02:00weekly0.8https://www.lif.se/lakemedelsstatistik/lakemedelsforetagens-forsaljning/2026-04-07T20:42:13+02:00weekly0.8https://www.lif.se/lakemedelsstatistik/apotekens-forsaljning/2026-04-07T20:42:30+02:00weekly0.8https://www.lif.se/lakemedelsstatistik/kostnader-for-lakemedel-i-sverige/2026-04-29T09:37:11+02:00weekly0.8https://www.lif.se/lakemedelsstatistik/sveriges-export-och-import-av-lakemedel/2026-04-29T10:22:57+02:00weekly0.8https://www.lif.se/lakemedelsstatistik/lakemedlen-det-saljs-mest-av/2026-08-19T08:59:40+02:00weekly0.8https://www.lif.se/lakemedelsstatistik/manadens-forsaljningsstatistik/2026-10-05T16:24:59+02:00weekly0.8https://www.lif.se/lakemedelsstatistik/korrigerad-kostnadsutveckling-for-lakemedel/2026-06-18T10:11:47+02:00weekly0.8https://www.lif.se/lakemedelsstatistik/kliniska-provningar/2025-10-20T11:59:00+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/ledare-jonas-vikman-53-20-darfor-drojer-vaccin-mot-coronavirus/2025-10-08T20:15:47+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/ledare-anders-blanck-233-20-coronapandemin-maste-fa-snabb-medicinsk-losning/2025-10-11T00:00:44+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/gastblogg-nathalie-moll-covid-19--fighting-the-fakes/2025-10-10T22:15:31+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/analys-johan-brun-273-20-besked-behovs-om-effektiv-covid-19-behandling/2025-10-08T20:19:02+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/analys-johan-brun-34-20-utokad-testning-av-covid-19/2025-10-11T02:40:32+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/ledare-anders-blanck-34-20-eu-maste-agera-mot-panikatgarder/2025-10-08T20:15:16+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-84-20-nar-ska-pandemin-ta-slut/2025-10-08T20:15:48+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/gastblogg-nathalie-moll-partnership-and-collaboration-the-new-normal-in-the-fight-against-covid-19/2025-10-08T20:15:48+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-214--20-fragorna-ar-fler-an-svaren--vad-vet-vi-sakert-om-coronapandemin/2025-10-08T17:17:50+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/gastblogg-234-20-nathalie-moll-covid-19--europes-fight-against-covid-19-seeing-the-best-in-people/2025-10-08T19:00:11+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-244--20-ar-utvecklingen-av-covid-19-pandemin-forutsagbar-eller-maste-vi-bara-vanta-och-se/2025-10-11T05:24:43+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/ledare-jonas-vikman-214-20-borja-forbered-infor-coronavaccinering/2025-10-08T18:44:27+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/analys-dag-larsson-284--20-behandling-av-covid-19--vi-behover-bade-snabbhet-och-sakerhet/2026-01-07T11:34:31+01:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-304--20-fler-studier-mer-kunskap-men-fortsatt-stort-tolkningsutrymme/2025-10-08T20:15:17+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-85--20-nu-borjar-vi-se-ljuset-i-tunneln--men-vi-ar-inte-dar-an/2025-10-08T20:17:29+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/analys-dag-larsson-125--20-kombinera-kvantitet-med-kvalitet/2026-01-07T11:34:30+01:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-155--20-ar-vi-alla-snart-smittade-och-hur-manga-blir-immuna/2025-10-08T20:17:26+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-225--20-dags-att-utvardera-den-svenska-strategin/2025-10-08T20:12:56+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-295-20-har-vi-overskattat-bade-dodlighet-och-smittsamhet/2025-10-11T04:55:23+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-56--20-nedatgaende-trender-men-ocksa-nya-utbrott---nar-ska-det-ta-slut/2025-10-08T20:12:56+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-126--20-ett-fortsatt-oforutsagbart-virus/2025-10-08T20:12:59+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-186--20-sma-steg-mot-okad-forstaelse-av-viruset/2025-10-10T21:18:37+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-266--20-lovande-nationell-utveckling-men-fortsatt-risk-for-lokala-utbrott/2025-10-08T20:13:00+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-58--20-tydlig-svensk-nedgang-men-oklar-orsak/2025-10-08T20:17:42+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-138--20-farre-sjuka-forsvarar-forskning/2025-10-08T20:15:12+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-208--20-vaccinrace-och-munskydd-praglar-debatten/2025-10-08T20:15:47+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-288--20-mer-smittsamt-men-snallare-virus-trolig-trend/2025-10-08T20:15:14+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-39--20-har-vi-lamnat-skamvran/2025-10-08T20:17:26+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-109--20-forskningen-ger-nya-uppslag/2025-10-11T02:55:26+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-169--20-covid-19--vem-drabbas-mest-och-hur-kan-vi-forutspa-det/2025-10-08T20:17:27+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-239--20-lakemedelsbranschen-oppnar-upp-men-storbritannien-stanger-ner/2025-10-08T20:15:48+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-110--20-nedatgaende-trenden-bruten---fortsatt-social-distansering-kan-bromsa/2025-10-08T20:17:28+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-810--20-coronapandemin-fortsatter-att-utmana/2025-10-08T20:15:12+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-1510--20-kommer-flockimmunitet-eller-vaccin-forst--vad-ska-stoppa-pandemin/2025-10-08T20:17:27+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-2310--20-covid-19-och-vacciner--vad-vet-vi-och-hur-kommer-det-att-bli/2025-10-08T20:17:40+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-2910--20-minskad-dodlighet-i-covid-19-men-fler-langtidssjuka/2025-10-08T20:19:03+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-611--20-vaccinstudier-visar-lovande-resultat/2025-10-08T20:15:49+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-1211--20-lovande-vaccinstudier-ljus-i-tunneln/2025-10-08T20:15:14+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-1911--20-gemensamt-ansvarstagande-kravs-i-vantan-pa-vacciner/2025-10-08T17:40:56+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-2611--20-manga-val-praglar-smittskyddsarbetet-och-kommande-vaccinstrategier/2025-10-10T21:15:54+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-412--20-pandemin-behaller-sitt-grepp-om-europa/2025-10-08T19:47:41+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-1012--20-kommande-vaccinationer-en-logistisk-utmaning/2025-10-08T20:19:01+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-1712--20-kan-kombinationer-av-olika-vacciner-forbattra-effekten/2025-10-10T17:45:35+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-71--21-coronaviruset-kommer-att-fortsatta-att-overraska-2021/2025-10-08T20:19:03+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-141--21-lovande-vaccinstart-med-fa-biverkningar/2025-10-08T20:12:54+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-211--21-mer-forskning-behovs---men-kvaliteten-maste-hojas/2025-10-09T23:33:53+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-271--21-battre-behandlingsmetoder-mot-covid-19-kommer/2025-10-10T10:40:11+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-32--21-muterande-virus-fortsatter-oroa/2025-10-08T20:12:54+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-112--21-viruset-som-aldrig-slutar-forvana-oss/2025-10-08T20:15:18+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-182--21-ar-vaccinerna-effektivare-an-vad-vi-tror/2025-10-08T20:12:58+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-242--21-mutationer--en-fortsatt-utmaning-for-vaccinforskningen/2025-10-08T20:13:00+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-43--21-det-ar-inte-over-an--bade-nya-vacciner-och-behandlingar-ar-efterlangtade/2025-10-10T01:27:34+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-113--21-vaccinernas-effekt-borjar-synas/2025-10-08T19:18:05+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-233--21-global-samverkan-kravs-for-att-fa-i-gang-vaccinationerna/2025-10-11T03:18:48+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-313--21-nya-smittspridningsmonster-och-fler-yngre-drabbade/2025-10-08T14:19:57+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-74--21-nya-mutationerna-ger-svarare-infektioner/2025-10-10T06:29:45+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-144--21-langtidscovid-i-stort-behov-av-battre-forstaelse-och-behandling/2025-10-09T06:42:50+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-214--21-tredje-vagen-har-annu-inte-vant/2025-10-08T20:17:28+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-284--21-ett-gemensamt-ansvarstagande-kravs-for-att-fa-slut-pa-pandemin/2025-10-08T20:19:01+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-55--21-kommande-vaccinstudier-en-utmaning/2025-10-09T09:10:09+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-115--21-nar-pandemin-blir-en-endemi/2025-10-08T20:19:03+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-195--21-allt-battre-men-stora-skillnader-i-varlden/2025-10-08T15:53:02+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-265--21-det-gar-at-ratt-hall/2025-10-09T01:22:25+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-26--21-nar-ar-pandemin-over/2025-10-08T18:30:46+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-96--21-svensk-forskning-bidrar-med-en-ny-typ-av-vaccin-som-skulle-kunna-losa-distributionsproblem/2025-10-10T08:43:39+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-166--21-vaccineffekterna-allt-tydligare/2025-10-09T19:25:53+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-236--21-fira-fortsatt-forsiktigt/2025-10-08T20:12:57+02:00weekly0.8https://www.lif.se/forskningsoversikt-coronavirus/kronika-johan-brun-306--21-slutet-pa-pandemin-narmar-sig/2025-10-08T19:32:56+02:00weekly0.8https://www.lif.se/dataskydd/life-time.se2025-10-08T17:49:21+02:00weekly0.8https://www.lif.se/dataskydd/etik/2025-10-08T21:37:55+02:00weekly0.8https://www.lif.se/dataskydd/fass/2025-10-08T13:43:57+02:00weekly0.8https://www.lif.se/dataskydd/reklameralakemedel-se-lif-jourtelefon-och-roda-webben/2025-10-09T01:05:14+02:00weekly0.8https://www.lif.se/dataskydd/leverantor/2025-10-08T19:38:50+02:00weekly0.8https://www.lif.se/dataskydd/deltagare/2025-10-08T15:02:14+02:00weekly0.8https://www.lif.se/dataskydd/medlemsforetag/2025-10-09T06:16:43+02:00weekly0.8https://www.lif.se/dataskydd/rekrytering/2025-10-09T06:16:43+02:00weekly0.8https://www.lif.se/dataskydd/city-life/2025-10-09T06:16:45+02:00weekly0.8https://www.lif.se/dataskydd/anvandare/2025-10-08T21:12:36+02:00weekly0.8https://www.lif.se/dataskydd/medverkande/2025-10-09T06:16:46+02:00weekly0.8https://www.lif.se/dataskydd/bokalakemedelsutbildning.se2025-10-09T22:54:56+02:00weekly0.8https://www.lif.se/dataskydd/databasen-hitta-kliniska-studier-hiks/2025-10-08T18:38:38+02:00weekly0.8https://www.lif.se/sa-funkar-det/reklamationer-och-indragningar/2026-05-26T11:07:29+02:00weekly0.8https://www.lif.se/sa-funkar-det/forskning--utveckling/2025-10-08T13:32:59+02:00weekly0.8https://www.lif.se/sa-funkar-det/myndighetsgodkannande/2025-10-08T13:33:03+02:00weekly0.8https://www.lif.se/sa-funkar-det/farmakologi/2025-10-08T13:32:59+02:00weekly0.8https://www.lif.se/sa-funkar-det/lakemedelsforman/2026-04-21T08:17:03+02:00weekly0.8https://www.lif.se/sa-funkar-det/lakemedel-och-miljo/2026-01-07T11:34:52+01:00weekly0.8https://www.lif.se/sa-funkar-det/e-verifikation/2025-10-08T13:32:58+02:00weekly0.8https://www.lif.se/sa-funkar-det/immaterialratt-inom-life-science/2025-10-08T13:32:59+02:00weekly0.8https://www.lif.se/sa-funkar-det/lakemedelssakerhet/2025-10-08T13:34:28+02:00weekly0.8https://www.lif.se/sa-funkar-det/klimatforandringarna/2025-10-08T13:34:26+02:00weekly0.8https://www.lif.se/sa-funkar-det/halsodata/2025-10-08T13:32:59+02:00weekly0.8https://www.lif.se/press/presskontakt/2026-01-07T11:35:19+01:00weekly0.8https://www.lif.se/press/pressbilder/2026-09-23T12:35:08+02:00weekly0.8https://www.lif.se/press/lif-i-debatten/2026-10-01T09:57:35+02:00weekly0.8https://www.lif.se/kalendarium/2022/2022-01-17T08:55:30+01:00weekly0.8https://www.lif.se/om-lif/kontakt/2025-10-08T13:32:43+02:00weekly0.8https://www.lif.se/om-lif/styrelse/2026-09-21T08:11:11+02:00weekly0.8https://www.lif.se/om-lif/remissvar2/2026-04-21T08:07:44+02:00weekly0.8https://www.lif.se/om-lif/medlemmar/2025-10-08T13:33:09+02:00weekly0.8https://www.lif.se/om-lif/medlemsskap-i-lif/2026-03-02T09:03:42+01:00weekly0.8https://www.lif.se/om-lif/vara-skrivelser/2025-10-08T13:35:04+02:00weekly0.8https://www.lif.se/om-lif/om-fass/2026-03-06T13:52:23+01:00weekly0.8https://www.lif.se/om-lif/prenumerera-pa-lifs-nyhetsbrev/2026-04-17T10:18:46+02:00weekly0.8https://www.lif.se/om-lif/karriar-pa-lif/2026-08-31T15:56:39+02:00weekly0.8https://www.lif.se/om-lif/vi-pa-lif/2026-09-14T13:27:13+02:00weekly0.8https://www.lif.se/nyheter/2025-04-17T16:38:54+02:00weekly0.9https://www.lif.se/om-lif/2025-10-08T13:32:46+02:00weekly0.9https://www.lif.se/sa-funkar-det/2025-10-08T13:33:24+02:00weekly0.9https://www.lif.se/material-och-dokument/2026-07-06T13:48:52+02:00weekly0.9https://www.lif.se/fokusomraden/2026-09-24T08:42:28+02:00weekly0.9https://www.lif.se/etik/2026-03-19T14:52:31+01:00weekly0.9https://www.lif.se/event/2025-10-08T13:33:22+02:00weekly0.9https://www.lif.se/lakemedelsstatistik/2026-05-19T11:13:49+02:00weekly0.9https://www.lif.se/2026-10-13T11:20:26+02:00weekly1